Akums Drugs & Pharmaceuticals Ltd

Akums Drugs & Pharmaceuticals Ltd Akums is India’s largest Contract Development and Manufacturing Organization (CDMO), holding a leading position in the domestic market.
(228)

India Focused Leading Pharma Contract Manufacturer
Pharma | Nutra | Cosmetics | Derma | API
Innovating for a Healthier Tomorrow
In FY23, Akums captured a 9.3% market share by value in the Indian domestic CDMO market, with an 8.8% share by volume in the Indian Pharmaceutical Market (IPM). By FY24, its market share by value increased to 10.0%, with a significan

t 30.2% share by value within the domestic CDMO market. Akums operates 15 state-of-the-art facilities producing a wide range of modern dosage forms across multiple therapeutic segments.

Behind every healthier generation is a foundation of care.This Mother’s Day, we honour all the mothers who inspire us to...
10/05/2026

Behind every healthier generation is a foundation of care.
This Mother’s Day, we honour all the mothers who inspire us to deliver better health, every day.

Advancing innovation where it matters the most.The launch of this advanced antibiotic marks another step toward addressi...
09/05/2026

Advancing innovation where it matters the most.

The launch of this advanced antibiotic marks another step toward addressing multidrug-resistant infections — a growing challenge in modern healthcare and critical care management.

As resistance patterns evolve, timely pharmaceutical innovation becomes essential in supporting better treatment outcomes, enabling effective interventions, and strengthening patient care.

With patient-centricity at the core, the focus remains on enabling access to advanced therapies that support better clinical outcomes and strengthen the future of critical care treatment.

Read full story here: https://pharma.economictimes.indiatimes.com/news/drug-approvals-and-launches/akums-launches-antibiotic-for-drug-resistant-infections/130576646

doesn’t just come from biology. It comes from where you live.Your pin code can shape exposure, access to care, and ult...
05/05/2026

doesn’t just come from biology. It comes from where you live.

Your pin code can shape exposure, access to care, and ultimately health outcomes.

From polluted air and high-traffic zones to limited green spaces and delayed healthcare access, the environment around us plays a powerful role in asthma risk especially for children.

This isn’t just about lungs.

It’s about infrastructure, awareness, and equity.

At Akums, we recognize that better health outcomes require more than treatment, they require accessible, high-quality respiratory solutions designed for real-world challenges.

Through science-backed formulations and scalable manufacturing, Akums empowers brands to deliver effective respiratory care helping bridge gaps where they matter most.

Because when it comes to breathing better, innovation must reach every pin code.

01/05/2026

Summer doesn’t hold back, your products shouldn’t either.

From intense UV exposure to dehydration and skin stress, seasonal challenges demand more than basic formulations. Today’s sun care needs to go beyond protection delivering performance, comfort, and real-world usability.

At Akums Drugs and Pharmaceuticals Ltd., we enable brands with advanced suncare solutions designed for efficacy, scalability, and market readiness.From concept to compliant, shelf-ready products, we help you launch smarter this summer.

29/04/2026

All formats. One partner. Seamless ex*****on.

With Akums Drugs and Pharmaceuticals Ltd., brands gain access to a comprehensive range of dosage formats—tablets, capsules, syrups, injections, and powders delivered with precision and consistency.

From development to delivery, everything is integrated under one roof ensuring efficiency, quality, and speed at every stage.

Because true scale comes from having the right partner across every format.

24/04/2026

Your product’s success is powered by what happens behind the scenes.

In today’s pharma landscape, speed and impact are shaped not just by ideas, but by seamless ex*****on, strong compliance, scalable manufacturing, and integrated processes.

At Akums Drugs and Pharmaceuticals Ltd., we enable brands to strengthen their backend so innovation reaches the market faster and more effectively.

Because success isn’t just about launching first.
It’s about launching right.

22/04/2026

Another year. Another milestone. One stronger team.

Akums family came together to celebrate our 22nd anniversary building memories, strengthening bonds, and setting the tone for what’s next.

A proud moment for Akums Drugs and Pharmaceuticals.Akums has been honoured with the Excellence in R&D and Pharma Innovat...
21/04/2026

A proud moment for Akums Drugs and Pharmaceuticals.

Akums has been honoured with the Excellence in R&D and Pharma Innovation of the Year award at The Financial Express Pharma Summit & Awards 2026.

This recognition reflects our unwavering focus on innovation, scientific excellence, and advancing healthcare through cutting-edge R&D. It reinforces our commitment to building future-ready solutions that create meaningful impact across the industry.

19/04/2026

What started as a bold vision has evolved into a force shaping India’s pharmaceutical landscape.

For 22 years, Akums has been at the forefront of transforming ideas into impactful healthcare solutions bridging science with scale, and innovation with accessibility. Our journey has been fueled by a relentless focus on quality, forward-thinking R&D, and the ability to adapt to an ever-evolving healthcare ecosystem.

This milestone is a reflection of the trust our partners place in us and the purpose that drives us to enable better healthcare outcomes, every single day.

Your everyday habits could be silently damaging your liver.This World Liver Day, look beyond the obvious — Long sitting ...
19/04/2026

Your everyday habits could be silently damaging your liver.

This World Liver Day, look beyond the obvious — Long sitting hours, excess sugar, poor sleep… the real triggers we ignore daily.

Fatty liver doesn’t speak early.

But it builds, quietly.

The good news? It’s reversible.
With awareness, consistency, and the right choices.

At Akums, we believe better health begins with better awareness — because prevention should never come late.

18/04/2026

Rising concerns around syrup contamination demand safer, more reliable solutions.

Powered by ClearDose Technology, this next-generation cough syrup formulation combines Levosalbutamol, Ambroxol, and Guaiphenesin to work across multiple mechanisms, supporting bronchodilation, mucus thinning, and improved expectoration.

Designed for effective and dependable performance, the formulation is DCGI approved, backed by 12-month stability data, patent filed, and ready for commercialization.

A new standard in liquid medicines.
Partner with us today.

Address

Plot No. 131 To 133, Block-C, Mangolpuri Ind. Area
Delhi
110083

Opening Hours

Monday 9:30am - 6:30pm
Tuesday 9:30am - 6:30pm
Wednesday 9:30am - 6:30pm
Thursday 9:30am - 6:30pm
Friday 9:30am - 6:30pm
Saturday 9:30am - 6:30pm

Telephone

+919999012080

Website

Alerts

Be the first to know and let us send you an email when Akums Drugs & Pharmaceuticals Ltd posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Akums Drugs & Pharmaceuticals Ltd:

Shortcuts

Share

Category